Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study

PURPOSE: The selection of safe and efficacious anticancer regimens for treatment of patients with broadly refractory metastatic cancers remains a clinical challenge. Such patients are often fatigued by toxicities of prior failed treatments and may have no further viable standard of care treatment op...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Darshana, Akolkar, Dadasaheb, Nagarkar, Rajnish, Srivastava, Navin, Datta, Vineet, Patil, Sanket, Apurwa, Sachin, Srinivasan, Ajay, Datar, Rajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822573/
https://www.ncbi.nlm.nih.gov/pubmed/36620556
http://dx.doi.org/10.3389/fonc.2022.972322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822573/
https://www.ncbi.nlm.nih.gov/pubmed/36620556
http://dx.doi.org/10.3389/fonc.2022.972322

Ejemplares similares